BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 18259943)

  • 1. The tyrphostin B42 inhibits cell proliferation and HER-2 autophosphorylation in cervical carcinoma cell lines.
    Soto-Cruz I; Rangel-Corona R; Valle-Mendiola A; Moreno-Morales X; Santiago-Pérez R; Weiss-Steider B; Cáceres-Cortés JR
    Cancer Invest; 2008 Mar; 26(2):136-44. PubMed ID: 18259943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
    Brunton VG; Carlin S; Workman P
    Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrphostin AG1024 accelerates the degradation of phosphorylated forms of retinoblastoma protein (pRb) and restores pRb tumor suppressive function in melanoma cells.
    von Willebrand M; Zacksenhaus E; Cheng E; Glazer P; Halaban R
    Cancer Res; 2003 Mar; 63(6):1420-9. PubMed ID: 12649208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel actions of tyrphostin AG 879: inhibition of RAF-1 and HER-2 expression combined with strong antitumoral effects on breast cancer cells.
    Larsson LI
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2624-31. PubMed ID: 15526167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
    Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
    J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of KIT, EGFR, HER-2 and tyrosine phosphorylation in undifferentiated thyroid carcinoma: implication for a new therapeutic approach.
    Murakawa T; Tsuda H; Tanimoto T; Tanabe T; Kitahara S; Matsubara O
    Pathol Int; 2005 Dec; 55(12):757-65. PubMed ID: 16287490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth.
    Takai N; Jain A; Kawamata N; Popoviciu LM; Said JW; Whittaker S; Miyakawa I; Agus DB; Koeffler HP
    Cancer; 2005 Dec; 104(12):2701-8. PubMed ID: 16265675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrphostin AG1478 suppresses proliferation and invasion of human breast cancer cells.
    Zhang YG; Du Q; Fang WG; Jin ML; Tian XX
    Int J Oncol; 2008 Sep; 33(3):595-602. PubMed ID: 18695891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transactivation of HER2 by vasoactive intestinal peptide in experimental prostate cancer: Antagonistic action of an analog of growth-hormone-releasing hormone.
    Sotomayor S; Carmena MJ; Schally AV; Varga JL; Sánchez-Chapado M; Prieto JC; Bajo AM
    Int J Oncol; 2007 Nov; 31(5):1223-30. PubMed ID: 17912451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regeneration of human epidermis on acellular dermis is impeded by small-molecule inhibitors of EGF receptor tyrosine kinase.
    Forsberg S; Ostman A; Rollman O
    Arch Dermatol Res; 2008 Oct; 300(9):505-16. PubMed ID: 18446355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu raises SHP-2, stops IFN-gamma anti-proliferation in bladder cancer.
    Su WP; Tu IH; Hu SW; Yeh HH; Shieh DB; Chen TY; Su WC
    Biochem Biophys Res Commun; 2007 Apr; 356(1):181-6. PubMed ID: 17346677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells.
    Tsai CM; Levitzki A; Wu LH; Chang KT; Cheng CC; Gazit A; Perng RP
    Cancer Res; 1996 Mar; 56(5):1068-74. PubMed ID: 8640763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu.
    Hong RL; Spohn WH; Hung MC
    Clin Cancer Res; 1999 Jul; 5(7):1884-91. PubMed ID: 10430096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An aberrant autocrine activation of the platelet-derived growth factor alpha-receptor in follicular and papillary thyroid carcinoma cell lines.
    Chen KT; Lin JD; Liou MJ; Weng HF; Chang CA; Chan EC
    Cancer Lett; 2006 Jan; 231(2):192-205. PubMed ID: 16126335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrphostins that suppress the growth of human papilloma virus 16-immortalized human keratinocytes.
    Ben-Bassat H; Rosenbaum-Mitrani S; Hartzstark Z; Levitzki R; Chaouat M; Shlomai Z; Klein BY; Kleinberger-Doron N; Gazit A; Tsvieli R; Levitzki A
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1442-57. PubMed ID: 10454524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dehydroepiandrosterone inhibits the proliferation and induces the death of HPV-positive and HPV-negative cervical cancer cells through an androgen- and estrogen-receptor independent mechanism.
    Girón RA; Montaño LF; Escobar ML; López-Marure R
    FEBS J; 2009 Oct; 276(19):5598-609. PubMed ID: 19702826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin augments proliferation of breast cancer cells via transactivation of HER2.
    Soma D; Kitayama J; Yamashita H; Miyato H; Ishikawa M; Nagawa H
    J Surg Res; 2008 Sep; 149(1):9-14. PubMed ID: 18262553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extra-virgin olive oil polyphenols inhibit HER2 (erbB-2)-induced malignant transformation in human breast epithelial cells: relationship between the chemical structures of extra-virgin olive oil secoiridoids and lignans and their inhibitory activities on the tyrosine kinase activity of HER2.
    Menendez JA; Vazquez-Martin A; Oliveras-Ferraros C; Garcia-Villalba R; Carrasco-Pancorbo A; Fernandez-Gutierrez A; Segura-Carretero A
    Int J Oncol; 2009 Jan; 34(1):43-51. PubMed ID: 19082476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.